GlassScriptPhysician profile
Julie A Martin
NPI 1427054790
$2,155.77
in general payments reported to CMS, 2019-2025
22 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $67.78 · 2021: $646 · 2022: $293 · 2023: $365 · 2024: $265 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $350.50 | 2021 | |
| Abbvie INC. | $345.90 | 2019-2023 | |
| Biogen, INC. | $269.30 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $258.48 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $109.31 | 2019-2022 | |
| Myovant Sciences INC. | $109.00 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $106.61 | 2023-2025 | |
| Astellas Pharma US INC | $103.63 | 2023-2025 | Veozah |
| Gynesonics, INC. | $86.54 | 2022 | |
| Exeltis, USA INC. | $73.67 | 2019-2023 | Slynd |
| Daiichi Sankyo INC. | $71.55 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.91 | 2020-2023 | |
| Avion Pharmaceuticals | $38.45 | 2019-2021 | |
| Organon LLC | $37.09 | 2024 | |
| Pfizer INC. | $32.26 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $20.44 | 2025 | Femring, Intrarosa |
| Agile Therapeutics, INC. | $19.24 | 2021 | |
| Covidien LP | $18.28 | 2019 | |
| Merck Sharp & Dohme LLC | $17.66 | 2019 | |
| Hologic Sales and Service, LLC | $17.40 | 2023 | Thinprep 2000 Processor, Third Wave, Aptima |
| Monaghan Medical Corporation | $14.04 | 2023 | Aeroeclipse |
| Evofem Biosciences, INC. | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.